Overweight and prognosis in triple-negative breast cancer patients: a systematic review and meta-analysis

[1]  P. Goodwin,et al.  Association of Obesity With Breast Cancer Outcome in Relation to Cancer Subtypes: A Meta-Analysis , 2021, Journal of the National Cancer Institute.

[2]  G. Gartlehner,et al.  The performance of anthropometric tools to determine obesity: a systematic review and meta-analysis , 2020, Scientific Reports.

[3]  Erratum: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. , 2020, CA: a cancer journal for clinicians.

[4]  F. Xue,et al.  Body surface area, height, and body fat percentage as more sensitive risk factors of cancer and cardiovascular disease , 2020, Cancer medicine.

[5]  Candace Moore,et al.  Bayes' factor , 2020, Radiopaedia.org.

[6]  Fan Li,et al.  Clinicopathologic and Prognostic Significance of Body Mass Index (BMI) among Breast Cancer Patients in Western China: A Retrospective Multicenter Cohort Based on Western China Clinical Cooperation Group (WCCCG) , 2019, BioMed research international.

[7]  S. French,et al.  Nutrition quality of food purchases varies by household income: the SHoPPER study , 2019, BMC Public Health.

[8]  J. Manson,et al.  Association of Body Fat and Risk of Breast Cancer in Postmenopausal Women With Normal Body Mass Index: A Secondary Analysis of a Randomized Clinical Trial and Observational Study , 2019, JAMA oncology.

[9]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[10]  Mengmeng Xu,et al.  Association between obesity with disease-free survival and overall survival in triple-negative breast cancer , 2018, Medicine.

[11]  J. Ockene,et al.  Association between Post-Cancer Diagnosis Dietary Inflammatory Potential and Mortality among Invasive Breast Cancer Survivors in the Women's Health Initiative , 2018, Cancer Epidemiology, Biomarkers & Prevention.

[12]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[13]  Eric-Jan Wagenmakers,et al.  UvA-DARE ( Digital Academic Repository ) Estimates of Between-Study Heterogeneity for 705 Meta-Analyses Reported in Psychological Bulletin From 1990 – 2013 , 2017 .

[14]  E. Wagenmakers,et al.  A Bayesian model-averaged meta-analysis of the power pose effect with informed and default priors: the case of felt power , 2017 .

[15]  N. Abda,et al.  Overweight: Is It a Prognostic Factor in Women with Triple-Negative Breast Cancer? , 2017, Asian Pacific journal of cancer prevention : APJCP.

[16]  A. Batterham,et al.  Prediction of whole-body fat percentage and visceral adipose tissue mass from five anthropometric variables , 2017, PloS one.

[17]  D. Meldrum,et al.  Obesity pandemic: causes, consequences, and solutions-but do we have the will? , 2017, Fertility and sterility.

[18]  J. Tchou,et al.  Breast cancer subtype distribution is different in normal weight, overweight, and obese women , 2017, Breast Cancer Research and Treatment.

[19]  J. Balko,et al.  Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease , 2016, Nature Reviews Clinical Oncology.

[20]  Jelle J Goeman,et al.  Plea for routinely presenting prediction intervals in meta-analysis , 2016, BMJ Open.

[21]  Marek Krawczuk,et al.  Body surface area formulae: an alarming ambiguity , 2016, Scientific Reports.

[22]  Mef Nilbert,et al.  Socioeconomic inequalities in breast cancer incidence and mortality in Europe—a systematic review and meta-analysis , 2016, European journal of public health.

[23]  Maoli Wang,et al.  Impact of central obesity on prognostic outcome of triple negative breast cancer in Chinese women , 2016, SpringerPlus.

[24]  A. Baldwin,et al.  The NF-κB Pathway and Cancer Stem Cells , 2016, Cells.

[25]  V. Apostolopoulos,et al.  The complex immunological and inflammatory network of adipose tissue in obesity. , 2016, Molecular nutrition & food research.

[26]  X. Shu,et al.  Body mass index and weight change in relation to triple-negative breast cancer survival , 2016, Cancer Causes & Control.

[27]  M. Beckmann,et al.  The influence of obesity on survival in early, high-risk breast cancer: results from the randomized SUCCESS A trial , 2015, Breast Cancer Research.

[28]  Keda Yu,et al.  Overweight as a Prognostic Factor for Triple-Negative Breast Cancers in Chinese Women , 2015, PloS one.

[29]  F. Nuttall.  Body Mass Index , 2015, Nutrition today.

[30]  Chunyan He,et al.  Toll-Like Receptor 4 Prompts Human Breast Cancer Cells Invasiveness via Lipopolysaccharide Stimulation and Is Overexpressed in Patients with Lymph Node Metastasis , 2014, PloS one.

[31]  Jeffrey W Pollard,et al.  Tumor-associated macrophages: from mechanisms to therapy. , 2014, Immunity.

[32]  M. Ellis,et al.  Body mass index, diabetes, and triple-negative breast cancer prognosis , 2014, Breast Cancer Research and Treatment.

[33]  Will Liao,et al.  The cellular and molecular origin of tumor-associated macrophages , 2014, Science.

[34]  P. Tugwell,et al.  The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses , 2014 .

[35]  J. Mackey,et al.  Obesity and survival in operable breast cancer patients treated with adjuvant anthracyclines and taxanes according to pathological subtypes: a pooled analysis , 2013, Breast Cancer Research.

[36]  Q. Chu,et al.  Does obesity have an effect on outcomes in triple-negative breast cancer? , 2013, The Journal of surgical research.

[37]  K. Altundag,et al.  The prognostic impact of obesity on molecular subtypes of breast cancer in premenopausal women. , 2013, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

[38]  E. Perez,et al.  Obesity at diagnosis is associated with inferior outcomes in hormone receptor‐positive operable breast cancer , 2012, Cancer.

[39]  G. Hortobagyi,et al.  Impact of body mass index on survival outcome among women with early stage triple-negative breast cancer. , 2012, Clinical breast cancer.

[40]  G. Frühbeck,et al.  Body mass index classification misses subjects with increased cardiometabolic risk factors related to elevated adiposity , 2012, International Journal of Obesity.

[41]  M. Pierobon,et al.  Obesity as a risk factor for triple-negative breast cancers: a systematic review and meta-analysis , 2012, Breast Cancer Research and Treatment.

[42]  J. Lambert.  Statistics in Brief: How to Assess Bias in Clinical Studies? , 2011, Clinical orthopaedics and related research.

[43]  J. Lambert.  How to Assess Bias in Clinical Studies , 2011 .

[44]  M. Ewertz,et al.  Effect of obesity on prognosis after early-stage breast cancer. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[45]  V. Montori,et al.  Diagnostic performance of body mass index to identify obesity as defined by body adiposity: a systematic review and meta-analysis , 2010, International Journal of Obesity.

[46]  K. Hess,et al.  Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[47]  F. Schmidt.  Meta-Analysis , 2008 .

[48]  S. Narod,et al.  Triple-Negative Breast Cancer: Clinical Features and Patterns of Recurrence , 2007, Clinical Cancer Research.

[49]  S. Kaestner,et al.  Chemotherapy dosing part I: scientific basis for current practice and use of body surface area. , 2007, Clinical oncology (Royal College of Radiologists (Great Britain)).

[50]  R. Yu,et al.  Circulating levels of MCP-1 and IL-8 are elevated in human obese subjects and associated with obesity-related parameters , 2006, International Journal of Obesity.

[51]  E. Feuer,et al.  SEER Cancer Statistics Review, 1975-2003 , 2006 .

[52]  J. Griggs,et al.  Undertreatment of obese women receiving breast cancer chemotherapy. , 2005, Archives of internal medicine.

[53]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[54]  Cathy J Bradley,et al.  Race, socioeconomic status, and breast cancer treatment and survival. , 2002, Journal of the National Cancer Institute.

[55]  S Duval,et al.  Trim and Fill: A Simple Funnel‐Plot–Based Method of Testing and Adjusting for Publication Bias in Meta‐Analysis , 2000, Biometrics.

[56]  I. Olkin,et al.  Meta-analysis of observational studies in epidemiology - A proposal for reporting , 2000 .

[57]  Steven Goodman.  Toward Evidence-Based Medical Statistics. 2: The Bayes Factor , 1999, Annals of Internal Medicine.

[58]  A. Henderson.  Evidence-Based Medicine—How to Practice and Teach EBM. D. L. Sackett, W. S. Richardson, W. Rosenberg, and R. B. Haynes. New York: Churchill Livingstone, 1997, 250 pp. Paperback, $24.99. ISBN 0-443-05686-2. , 1997 .

[59]  G. Smith,et al.  Bias in meta-analysis detected by a simple, graphical test , 1997, BMJ.

[60]  S. Satya‐Murti.  Evidence-based Medicine: How to Practice and Teach EBM , 1997 .